Clin Endosc.  2019 Nov;52(6):525-526. 10.5946/ce.2019.197.

Strategies to Overcome Risks Associated with Endoscopic Biliary Stenting

• Paik WH
• Kim YT

• KMID: 2465793
• DOI: http://doi.org/10.5946/ce.2019.197

Abstract

No abstract available.

MeSH Terms

Stents*

Reference

1. ASGE Technology Assessment Committee, Pfau PR, Pleskow DK, et al. Pancreatic and biliary stents. Gastrointest Endosc. 2013; 77:319–327.

2. Thaker AM, Mosko JD, Berzin TM. Post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastroenterol Rep (Oxf). 2015; 3:32–40.

3. Kim GH, Ryoo SK, Park JK, et al. Risk factors for pancreatitis and cholecystitis after endoscopic biliary stenting in patients with malignant extrahepatic bile duct obstruction. Clin Endosc. 2019; 52:598–605.

4. Jang S, Stevens T, Parsi M, et al. Association of covered metallic stents with cholecystitis and stent migration in malignant biliary stricture. Gastrointest Endosc. 2018; 87:1061–1070.

5. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001; 54:425–434.

6. Cao J, Peng C, Ding X, et al. Risk factors for post-ERCP cholecystitis: a single-center retrospective study. BMC Gastroenterol. 2018; 18:128.

7. Mine T, Morizane T, Kawaguchi Y, et al. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol. 2017; 52:1013–1022.